One Course of Adjuvant BEP in Clinical Stage I Nonseminoma Mature and Expanded Results from the SWENOTECA group.
(2014) In Annals of Oncology 25(11). p.2167-2172- Abstract
- SWENOTECA has since 1998 offered patients with clinical stage I (CS I) nonseminoma, adjuvant chemotherapy with one course of bleomycin, etoposide and cisplatin (BEP). The aim has been to reduce the risk of relapse, sparing patients the need of toxic salvage treatment. Initial results on 312 patients treated with one course of adjuvant BEP, with a median follow-up of 4.5 years, have been previously published. We now report mature and expanded results.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4614926
- author
- organization
- publishing date
- 2014
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Annals of Oncology
- volume
- 25
- issue
- 11
- pages
- 2167 - 2172
- publisher
- Oxford University Press
- external identifiers
-
- pmid:25114021
- wos:000344644200009
- scopus:84918827743
- pmid:25114021
- ISSN
- 1569-8041
- DOI
- 10.1093/annonc/mdu375
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Molecular Reproductive Medicine (013241710), Oncology, MV (013035000), Pediatrics/Urology/Gynecology/Endocrinology (013240400)
- id
- f69f4c56-faa0-4731-bfae-d084e78b6a5d (old id 4614926)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25114021?dopt=Abstract
- date added to LUP
- 2016-04-01 10:19:06
- date last changed
- 2022-05-13 07:37:27
@article{f69f4c56-faa0-4731-bfae-d084e78b6a5d, abstract = {{SWENOTECA has since 1998 offered patients with clinical stage I (CS I) nonseminoma, adjuvant chemotherapy with one course of bleomycin, etoposide and cisplatin (BEP). The aim has been to reduce the risk of relapse, sparing patients the need of toxic salvage treatment. Initial results on 312 patients treated with one course of adjuvant BEP, with a median follow-up of 4.5 years, have been previously published. We now report mature and expanded results.}}, author = {{Tandstad, T and Ståhl, Olof and Håkansson, Ulf and Dahl, O and Haugnes, H S and Klepp, O H and Langberg, C W and Laurell, A and Oldenburg, J and Solberg, A and Söderström, K and Cavallin-Ståhl, Eva and Stierner, U and Wahlquist, R and Wall, N and Cohn-Cedermark, G}}, issn = {{1569-8041}}, language = {{eng}}, number = {{11}}, pages = {{2167--2172}}, publisher = {{Oxford University Press}}, series = {{Annals of Oncology}}, title = {{One Course of Adjuvant BEP in Clinical Stage I Nonseminoma Mature and Expanded Results from the SWENOTECA group.}}, url = {{http://dx.doi.org/10.1093/annonc/mdu375}}, doi = {{10.1093/annonc/mdu375}}, volume = {{25}}, year = {{2014}}, }